Clin Mol Hepatol.
2024 Oct;30(4):656-658. 10.3350/cmh.2024.0499.
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
- Kim BK
1,2,3
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- 2Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea
- 3Yonsei Liver Center, Severance Hospital, Seoul, Korea
- KMID: 2560063
- DOI: http://doi.org/10.3350/cmh.2024.0499
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
- Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
- Hepatocellular Carcinoma Prediction Models for Patients with Chronic Hepatitis B Virus Infection in the Era of Potent Antiviral Therapy
- Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
- The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
